European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection
The European Union's drugs regulator on Thursday recommended approval of Eisai and Biogen's Leqembi for some patients with ...
Do I need a visa to go to Europe? What ETIAS is and the new travel rules for 2025
ETIAS will impact travelers from over 60 visa-exempt countries, including the United States. Here's what you need to know ...